Home » Topics » BioWorld Science

BioWorld Science
RSS

Kosan receives funds for drug design

Sep. 6, 1996

Generic product from Barr Laboratories cleared by FDA

Sep. 6, 1996

Abbott evaluating clitocine analogues

Sep. 6, 1996

VZIG clinical studies progress in post-herpetic neuralgia

Sep. 6, 1996

Russian launch for GMDP

Sep. 6, 1996

Abbott describes immunosuppressants

Sep. 6, 1996

Interferon production enhancer discovered by Japanese researchers

Sep. 6, 1996

CollaGenex and Istituto Gentili collaboration

Sep. 6, 1996

Higher doses recommended for Protovir study

Sep. 6, 1996

Anti-HIV activity reported for Onconase

Sep. 6, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...